Iovance Biotherapeutics Ownership | Who Owns Iovance Biotherapeutics?
Iovance Biotherapeutics Ownership Summary
Iovance Biotherapeutics is owned by 32.99% institutional investors, 1.10% insiders, and 65.92% retail investors. Vanguard group is the largest institutional shareholder, holding 9.08% of IOVA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.83% of its assets in Iovance Biotherapeutics shares.
IOVA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Iovance Biotherapeutics | 32.99% | 1.10% | 65.92% |
| Sector | Healthcare Stocks | 57.43% | 9.41% | 33.16% |
| Industry | Biotech Stocks | 69.02% | 8.92% | 22.06% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 27.53M | 9.08% | $203.75M |
| Mhr fund management | 24.42M | 8.05% | $180.69M |
| Blackrock | 21.23M | 7.97% | $170.23M |
| Blackrock funding, inc. /de | 23.48M | 7.74% | $173.72M |
| Perceptive advisors | 22.11M | 7.29% | $163.63M |
| State street | 12.63M | 4.74% | $101.25M |
| Hood river capital management | 8.99M | 2.96% | $66.54M |
| Soleus capital management | 6.56M | 2.16% | $48.54M |
| Geode capital management | 5.87M | 1.94% | $43.46M |
| T. rowe price investment management | 5.83M | 1.92% | $43.17M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Mhr fund management | 24.42M | 19.98% | $180.69M |
| Apis capital advisors | 1.36M | 6.72% | $10.09M |
| Perceptive advisors | 22.11M | 4.51% | $163.63M |
| Palo alto investors lp | 3.04M | 3.49% | $22.51M |
| Orion investment | 1.06M | 3.13% | $7.85M |
| Soleus capital management | 6.56M | 3.05% | $48.54M |
| Bioimpact capital | 2.67M | 2.81% | $19.79M |
| Parametrica management | 261.09K | 2.55% | $1.93M |
| Cm management | 300.00K | 1.98% | $2.22M |
| Stempoint capital lp | 949.40K | 1.75% | $7.03M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Man group | 2.41M | 0.05% | 2.41M |
| State street | 12.63M | 0.00% | 2.22M |
| Ubs group | 2.70M | 0.00% | 2.08M |
| Blackrock funding, inc. /de | 23.48M | 0.00% | 1.99M |
| Assenagon asset management | 1.75M | 0.02% | 1.75M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Perceptive advisors | 22.11M | 4.51% | -4.51M |
| Soleus capital management | 6.56M | 3.05% | -1.97M |
| Balyasny asset management | 2.82M | 0.03% | -1.65M |
| Summit partners public asset management | - | - | -1.56M |
| Opaleye management | - | - | -897.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Man group | 2.41M | 0.05% | 2.41M | $17.87M |
| Assenagon asset management | 1.75M | 0.02% | 1.75M | $12.93M |
| Raymond james financial | 1.56M | 0.00% | 1.56M | $11.57M |
| Artal group | 1.01M | 0.21% | 1.01M | $8.11M |
| Stempoint capital lp | 949.40K | 1.75% | 949.40K | $7.03M |
Sold Out
| Holder | Change |
|---|---|
| Capital performance advisors llp | -11.00 |
| Massmutual trust co fsb/adv | -28.00 |
| Cibc private wealth group | -35.00 |
| Nelson, van denburg & campbell wealth management group | -46.00 |
| Fifth third bancorp | -62.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 193 | -35.02% | 100,034,590 | -57.33% | 32 | 0.55% | 92 | -39.07% | 50 | -37.50% |
| Sep 30, 2024 | 292 | -5.19% | 234,393,808 | 0.82% | 77 | 1.01% | 149 | -17.22% | 80 | -2.44% |
| Jun 30, 2024 | 305 | 2.69% | 232,471,450 | 7.59% | 87 | 1.23% | 177 | 9.94% | 82 | -6.82% |
| Mar 31, 2024 | 297 | 18.33% | 216,063,214 | 4.25% | 84 | 1.19% | 161 | 13.38% | 88 | 31.34% |
| Dec 31, 2023 | 251 | 1.21% | 207,248,234 | -2.24% | 84 | 0.95% | 142 | -2.74% | 67 | 21.82% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 8.64M | 2.83% | 25.89K |
| Vanguard Small Cap Index | 7.00M | 2.30% | 12.47K |
| iShares Russell 2000 ETF | 7.15M | 2.18% | -139.85K |
| SPDR® S&P Biotech ETF | 5.94M | 1.81% | 44.80K |
| Hood River Small-Cap Growth Instl | 5.10M | 1.67% | 525.69K |
| Vanguard Small Cap Value Index Inv | 4.63M | 1.52% | -8.69K |
| Macquarie Small Cap Core I | 3.91M | 1.28% | 969.77K |
| Vanguard Institutional Extnd Mkt Idx Tr | 3.45M | 1.13% | 976.00 |
| Delaware Small Cap Core I | 2.61M | 0.86% | 1.84M |
| Fidelity Small Cap Index | 2.57M | 0.84% | -17.09K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 12, 2024 | Maynard Ryan D | - | Sell | $503.00K |
| Feb 20, 2024 | MCPEAK MERRILL A | - | Buy | $2.29M |
| Feb 20, 2024 | Dukes Iain D. | - | Buy | $292.80K |
| Feb 20, 2024 | Rothbaum Wayne P. | - | Buy | $45.75M |
| Sep 18, 2023 | MCPEAK MERRILL A | - | Buy | $55.60K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | - |
| 2024 Q4 | - | 1 |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | 3 | - |
IOVA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools